An overview of anthrax infection including the recently identified form of disease in injection drug users

Intensive Care Medicine

Volumn 38, Issue 7, 2012, Pages 1092-1104

  Hicks, Caitlin W ^a,b   Sweeney, Daniel A ^c   Cui, Xizhong ^b   Li, Yan ^b   Eichacker, Peter Q ^b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Washington Hospital   (United States)

Author keywords

Anthrax; Bacillus anthracis; Diagnosis; Pathogenesis; Treatment

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTHRAX VACCINE; AVA; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; FLUCLOXACILLIN; IMMUNOGLOBULIN; MEROPENEM; METRONIDAZOLE; PENICILLIN G; RAXIBACUMAB; RIFAMPICIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTHRAX; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; BACILLUS ANTHRACIS; BLOOD CULTURE; CLINICAL FEATURE; DRUG USE; GASTROINTESTINAL INFECTION; GERMANY; HUMAN; INCIDENCE; INHALATION; INJECTION DRUG USER; MICROBIOLOGY; PATHOGENESIS; POLYMERASE CHAIN REACTION; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; TISSUE CULTURE; TREATMENT DURATION; TREATMENT OUTCOME; UNITED KINGDOM;

ANTHRAX; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; BACILLUS ANTHRACIS; BIOTERRORISM; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; HUMANS; PENICILLINS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84862684662     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-012-2541-0     Document Type: Review

References (97)

1. M Mock A Fouet 2001 Anthrax Annu Rev Microbiol 55 647 671 11544370 10.1146/annurev.micro.55.1.647 1:CAS:528:DC%2BD3MXnslKjtb4%3D
2. PS Brachman 1980 Inhalation anthrax Ann N Y Acad Sci 353 83 93 7013615 10.1111/j.1749-6632.1980.tb18910.x 1:STN:280:DyaL3M7ot1GhsQ%3D%3D
3. Kiple KF (1993) The Cambridge world history of human disease. Cambridge University Press, Cambridge
4. SH Ringertz EA Høiby M Jensenius J Maehlen DA Caugant A Myklebust K Fossum 2000 Injectional anthrax in a heroin skin-popper Lancet 356 1574 1575 11075776 10.1016/S0140-6736(00)03133-0 1:STN:280:DC%2BD3M%2Fks1Oiug%3D%3D
5. WD Tutrone NS Scheinfeld JM Weinberg 2002 Cutaneous anthrax: a concise review Cutis 69 27 33 11829175
6. Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, McDade J, Osterholm MT, Parker G, Perl TM, Russell PK, Tonat K, Working Group on Civilian Biodefense 2002 Anthrax as a biological weapon, 2002: updated recommendations for management JAMA 287 2236 2252 10.1001/jama.287.17.2236
7. DN Kyriacou A Adamski N Khardori 2006 Anthrax: from antiquity and obscurity to a front-runner in bioterrorism Infect Dis Clin North Am 20 227 251 16762737 10.1016/j.idc.2006.03.009, viii
8. Eurosurveillance Editorial Team (2006) Probable human anthrax death in Scotland. Euro Surveill 11:E060817.060812
9. S Anaraki S Addiman G Nixon D Krahe R Ghosh T Brooks G Lloyd R Spencer A Walsh B McCloskey N Lightfoot 2008 Investigations and control measures following a case of inhalation anthrax in east London in a drum maker and drummer, October 2008 Euro Surveill 13 19076 19094916
10. Centers for Disease Control and Prevention (CDC) 2006 Inhalation anthrax associated with dried animal hides-Pennsylvania and New York city, 2006 MMWR Morb Mortal Wkly Rep 55 280 282
11. Lerner M (2011) 'Miracle man' wins fight with anthrax. In: Star tribune. The Star Tribune Media Company, Minnesota, 30 Aug 2011
12. MS Klempner EA Talbot SI Lee S Zaki MJ Ferraro 2010 Case records of the Massachusetts general hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock N Engl J Med 363 766 777 20818879 10.1056/NEJMcpc1003887 1:CAS:528:DC%2BC3cXhtVCrtb7N
13. International Office of Epizootics, World Health Organization, Food and Agriculture Organization of the United Nations (2008) Anthrax in humans and animals, 4th edn. World Health Organization, Geneva
14. GW Christopher TJ Cieslak JA Pavlin EM Eitzen Jr 1997 Biological warfare. A historical perspective JAMA 278 412 417 9244333 10.1001/jama.1997. 03550050074036 1:STN:280:DyaK2szos1Crtg%3D%3D
15. M Meselson J Guillemin M Hugh-Jones A Langmuir I Popova A Shelokov O Yampolskaya 1994 The Sverdlovsk anthrax outbreak of 1979 Science 266 1202 1208 7973702 10.1126/science.7973702 1:CAS:528:DyaK2MXit1GrtL4%3D
16. DB Jernigan PL Raghunathan BP Bell R Brechner EA Bresnitz JC Butler M Cetron M Cohen T Doyle M Fischer C Greene KS Griffith J Guarner JL Hadler JA Hayslett R Meyer LR Petersen M Phillips R Pinner T Popovic CP Quinn J Reefhuis D Reissman N Rosenstein A Schuchat WJ Shieh L Siegal DL Swerdlow FC Tenover M Traeger JW Ward I Weisfuse S Wiersma K Yeskey S Zaki DA Ashford BA Perkins S Ostroff J Hughes D Fleming JP Koplan JL Gerberding 2002 Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings Emerg Infect Dis 8 1019 1028 12396909
17. DA Sweeney CW Hicks X Cui Y Li PQ Eichacker 2011 Anthrax infection Am J Respir Crit Care Med 184 1333 1341 21852539 10.1164/rccm.201102-0209CI
18. United States Central Intelligence Agency (2012) The world factbook: field listing: illicit drugs. https://www.cia.gov/library/publications/the- world-factbook/fields/2086.html. Accessed 27 Jan 2012
19. P Del Giudice 2004 Cutaneous complications of intravenous drug abuse Br J Dermatol 150 1 10 14746612 10.1111/j.1365-2133.2004.05607.x
20. AG Powell JE Crozier H Hodgson DJ Galloway 2011 A case of septicaemic anthrax in an intravenous drug user BMC Infect Dis 11 21 21251266 10.1186/1471-2334-11-21 1:CAS:528:DC%2BC3MXhs1Srur0%3D
21. Murray PR, American Society for Microbiology (1995) Manual of clinical microbiology, 6th edn. ASM, Washington
22. Military Vaccine (MILVAX) Agency (2012) Anthrax vaccine immunization program: resource center. http://www.anthrax.osd.mil/resource/images/ imagesLarge.asp?imgId=35. Accessed 27 Jan 2012
23. AM Friedlander 2001 Tackling anthrax Nature 414 160 161 11700539 10.1038/35102660 1:CAS:528:DC%2BD3MXosFaisrw%3D
24. P Mikesell BE Ivins JD Ristroph 1983 Plasmids, pasteur, and anthrax ASM News 7 320
25. KA Bradley J Mogridge M Mourez RJ Collier JA Young 2001 Identification of the cellular receptor for anthrax toxin Nature 414 225 229 11700562 10.1038/n35101999 1:CAS:528:DC%2BD3MXosFahtrs%3D
26. MT Tippetts DL Robertson 1988 Molecular cloning and expression of the Bacillus anthracis edema factor toxin gene: a calmodulin-dependent adenylate cyclase J Bacteriol 170 2263 2266 2834337 1:CAS:528:DyaL1cXktFyisb4%3D
27. M Moayeri SH Leppla 2009 Cellular and systemic effects of anthrax lethal toxin and edema toxin Mol Aspects Med 30 439 455 19638283 10.1016/j.mam.2009.07. 003 1:CAS:528:DC%2BD1MXhtlyjt7bI
28. X Cui M Moayeri Y Li X Li M Haley Y Fitz R Correa-Araujo SM Banks SH Leppla PQ Eichacker 2004 Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats Am J Physiol Regul Integr Comp Physiol 286 R699 R709 14715494 10.1152/ajpregu.00593.2003 1:CAS:528:DC%2BD2cXjtlKrsLw%3D
29. X Cui Y Li X Li MW Laird M Subramanian M Moayeri SH Leppla Y Fitz J Su K Sherer PQ Eichacker 2007 Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model J Infect Dis 195 572 580 17230417 10.1086/510856 1:CAS:528:DC%2BD2sXitlOrsL8%3D
30. DA Sweeney X Cui SB Solomon DA Vitberg TS Migone D Scher RL Danner C Natanson GM Subramanian PQ Eichacker 2010 Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines J Infect Dis 202 1885 1896 21067373 10.1086/657408 1:CAS:528:DC%2BC3MXisFeqtQ%3D%3D
31. CW Hicks X Cui DA Sweeney Y Li A Barochia PQ Eichacker 2011 The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shock Toxins (Basel) 3 1185 1202 1:CAS:528:DC%2BC3MXhtlSns7fL
32. CW Hicks Y Li S Okugawa SB Solomon M Moayeri SH Leppla A Mohanty GM Subramanian TS Mignone Y Fitz X Cui PQ Eichacker 2011 Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model Am J Physiol Heart Circ Physiol 300 H1108 H1118 21217068 10.1152/ajpheart.01128.2010 1:CAS:528: DC%2BC3MXjs1GqsL0%3D
33. S Shafazand R Doyle S Ruoss A Weinacker TA Raffin 1999 Inhalational anthrax: epidemiology, diagnosis, and management Chest 116 1369 1376 10559102 10.1378/chest.116.5.1369 1:STN:280:DC%2BD3c%2FisFymsQ%3D%3D
34. Anbarasan E (2010) Anthrax outbreak hits Bangladesh. http://www.bbc.co. uk/news/world-south-asia-11183617. Accessed 27 Jan 2012
35. M Doganay G Metan E Alp 2010 A review of cutaneous anthrax and its outcome J Infect Public Health 3 98 105 20869669 10.1016/j.jiph.2010.07.004
36. MT Kutluk G Secmeer G Kanra A Celiker H Aksoyek 1987 Cutaneous anthrax Cutis 40 117 118 3621994 1:STN:280:DyaL2szgtlWnug%3D%3D
37. E Mallon PH McKee 1997 Extraordinary case report: cutaneous anthrax Am J Dermatopathol 19 79 82 9056659 10.1097/00000372-199702000-00014 1:STN:280:DyaK2s3gvFemuw%3D%3D
38. T Sirisanthana N Navachareon P Tharavichitkul V Sirisanthana AE Brown 1984 Outbreak of oral-oropharyngeal anthrax: an unusual manifestation of human infection with Bacillus anthracis Am J Trop Med Hyg 33 144 150 6696173 1:STN:280:DyaL2c7isFygsA%3D%3D
39. FA Abramova LM Grinberg OV Yampolskaya DH Walker 1993 Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979 Proc Natl Acad Sci U S A 90 2291 2294 8460135 10.1073/pnas.90.6.2291 1:STN:280: DyaK3s3htF2ntQ%3D%3D
40. A Alizad EM Ayoub N Makki 1995 Intestinal anthrax in a two-year-old child Pediatr Infect Dis J 14 394 395 7638018 10.1097/00006454-199505000-00013 1:STN:280:DyaK2MzmsFWktA%3D%3D
41. W Dutz E Kohout 1971 Anthrax Pathol Annu 6 209 248 5005212 1:STN:280:DyaE3s%2FhtFartg%3D%3D
42. DR Nalin B Sultana R Sahunja AK Islam MA Rahim M Islam BS Costa N Mawla WB Greenough 1977 Survival of a patient with intestinal anthrax Am J Med 62 130 132 835581 10.1016/0002-9343(77)90358-8 1:STN:280:DyaE2s7gvFSrsg%3D%3D
43. TC Dixon M Meselson J Guillemin PC Hanna 1999 Anthrax N Engl J Med 341 815 826 10477781 10.1056/NEJM199909093411107 1:STN:280:DyaK1MzptlSnug%3D%3D
44. HA Druett DW Henderson L Packman S Peacock 1953 Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores J Hyg (Lond) 51 359 371 10.1017/S0022172400015795 1:STN:280:DyaG2c%2FhslGmtQ%3D%3D
45. JE Holty DM Bravata H Liu RA Olshen KM McDonald DK Owens 2006 Systematic review: a century of inhalational anthrax cases from 1900 to 2005 Ann Intern Med 144 270 280 16490913
46. K Vessal J Yeganehdoust W Dutz E Kohout 1975 Radiological changes in inhalation anthrax. A report of radiological and pathological correlation in two cases Clin Radiol 26 471 474 811421 10.1016/S0009-9260(75)80100-0 1:STN:280:DyaE28%2FmsFSmuw%3D%3D
47. BJ Wood B DeFranco M Ripple M Topiel C Chiriboga V Mani K Barry D Fowler H Masur L Borio 2003 Inhalational anthrax: radiologic and pathologic findings in two cases Am J Roentgenol 181 1071 1078
48. MK Lalitha V Anandi N Walter JO Devadatta BM Pulimood 1988 Primary anthrax presenting as an injection "abscess" Indian J Pathol Microbiol 31 254 256 3148549 1:STN:280:DyaL1M7ntlWnsw%3D%3D
49. CC Berdjis CA Gleiser 1964 Experimental subcutaneous anthrax in chimpanzees Exp Mol Pathol 33 63 75 14117853 10.1016/0014-4800(64)90019-X 1:STN:280:DyaF2c%2FnsFGksQ%3D%3D
50. Ramsay CN, Stirling A, Smith J, Hawkins G, Brooks T, Hood J, Penrice G, Browning LM, Ahmed S (2010) An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland. Euro Surveill 15(2):pii=19465
51. Booth MG, Hood J, Brooks TJ, Hart A; Health Protection Scotland Anthrax Clinical Network 2011 Anthrax infection in drug users Lancet 375 1345 1346
52. Radun D, Bernard H, Altmann M, Schöneberg I, Bochat V, van Treeck U, Rippe RM, Grunow R, Elschner M, Biederbick W, Krause G (2010) Preliminary case report of fatal anthrax in an injecting drug user in North-Rhine-Westphalia, Germany, December 2009. Euro Surveill 15(2):pii=19464
53. G Beaumont 2010 Anthrax in a Scottish intravenous drug user J Forensic Leg Med 17 443 445 21056883 10.1016/j.jflm.2010.09.008
54. N Jallali S Hettiaratchy AC Gordon A Jain 2011 The surgical management of injectional anthrax J Plast Reconstr Aesthet Surg 64 276 277 20615773 10.1016/j.bjps.2010.06.003 1:STN:280:DC%2BC3M%2FmvFCqsw%3D%3D
55. BJ Parcell AD Wilmshurst AJ France L Motta T Brooks WJ Olver 2011 Injection anthrax causing compartment syndrome and necrotising fasciitis J Clin Pathol 64 95 96 21097792 10.1136/jcp.2010.082586
56. D Knox G Murray M Millar D Hamilton M Connor RD Ferdinand GA Jones 2011 Subcutaneous anthrax in three intravenous drug users: a new clinical diagnosis J Bone Joint Surg Br 93 414 417 21357967 10.1302/0301-620X.93B3.25976 1:STN:280:DC%2BC3M3is1agsA%3D%3D
57. N Johns D Cooper J Terrace 2011 An unusual case of peritonitis in an intravenous drug user Gastroenterology 141 435 436 21712037 10.1053/j.gastro. 2011.02.076, 780-781
58. Centers for Disease Control and Prevention (CDC) 2001 Update: investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001 MMWR Morb Mortal Wkly Rep 50 889 893
59. Centers for Disease Control and Prevention (CDC) 2001 Update: investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax MMWR Morb Mortal Wkly Rep 50 941 948
60. Centers for Disease Control and Prevention (CDC) 2001 Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001 JAMA 286 2226 2232 10.1001/jama.286.18.2226
61. EJ Stern KB Uhde SV Shadomy N Messonnier 2008 Conference report on public health and clinical guidelines for anthrax Emerg Infect Dis 14 07 0969 18394267 10.3201/eid1404.070969
62. A Athamna M Massalha M Athamna A Nura B Medlej I Ofek D Bast E Rubinstein 2004 In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity J Antimicrob Chemother 53 247 251 14688054 10.1093/jac/dkh016 1:CAS:528:DC%2BD2cXos1arsA%3D%3D
63. National Services Scotland (2011) Interim clinical management of suspected anthrax in drug users. Available via http://www.hps.scot.nhs.uk/ anthrax/documents/clinical-guidance-for-use-of-anthrax-immune-globulin-v12-1- 2010-03-19.pdf. Accessed 13 Dec 2011
64. Emergent BioSolutions Inc. (2009) Emergent BioSolutions announces commencement of phase I/II clinical trial of anthrax immune globulin for treating anthrax disease. Rockville, 17 March 2009
65. Centers for Disease Control and Prevention (CDC) (2006) E-IND protocol: one time emergency use of liquid 5% anthrax immune globulin for treatment of severe anthrax. CDC, Atlanta, 22 February 2006
66. X Cui Y Li M Moayeri GH Choi GM Subramanian X Li M Haley Y Fitz J Feng SM Banks SH Leppla PQ Eichacker 2005 Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis J Infect Dis 191 422 434 15633102 10.1086/427189 1:CAS:528:DC%2BD2MXhtlKrur8%3D
67. TS Migone GM Subramanian J Zhong LM Healey A Corey M Devalaraja L Lo S Ullrich J Zimmerman A Chen M Lewis G Meister K Gillum D Sanford J Mott SD Bolmer 2009 Raxibacumab for the treatment of inhalational anthrax N Engl J Med 361 135 144 19587338 10.1056/NEJMoa0810603 1:CAS:528:DC%2BD1MXosVKrt7c%3D
68. Human Genome Sciences (HGS) (2011) Raxibacumab (ABthrax). http://www.hgsi.com/abthrax-raxibacumab.html. Accessed 15 Dec 2011
69. Z Chen M Moayeri D Crown S Emerson I Gorshkova P Schuck SH Leppla RH Purcell 2009 Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody Infect Immun 77 3902 3908 19528217 10.1128/IAI.00200-09 1:CAS:528:DC%2BD1MXhtFehsbfF
70. Z Chen M Moayeri H Zhao D Crown SH Leppla RH Purcell 2009 Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding Proc Natl Acad Sci U S A 106 13487 13492 19651602 10.1073/pnas.0906581106 1:CAS:528:DC%2BD1MXhtVOitrrL
71. G Li Y Qu C Cai Y Kong S Liu J Zhang J Zhao L Fu J Xu W Chen 2009 The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody Biochem Biophys Res Commun 385 591 595 19486894 10.1016/j.bbrc.2009.05.114 1:CAS:528:DC%2BD1MXnsFKms7w%3D
72. AK Hull CJ Criscuolo V Mett H Groen W Steeman H Westra G Chapman B Legutki L Baillie V Yusibov 2005 Human-derived, plant-produced monoclonal antibody for the treatment of anthrax Vaccine 23 2082 2086 15755575 10.1016/j.vaccine.2005.01.013 1:CAS:528:DC%2BD2MXitVCgsLY%3D
73. MT Albrecht H Li ED Williamson CS LeButt HC Flick-Smith CP Quinn H Westra D Galloway A Mateczun S Goldman H Groen LW Baillie 2007 Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax Infect Immun 75 5425 5433 17646360 10.1128/IAI.00261-07 1:CAS:528:DC%2BD2sXht1CrtLvF
74. MA Wild K Kumor MJ Nolan H Lockman KS Bowdish 2007 A human antibody against anthrax protective antigen protects rabbits from lethal infection with aerosolized spores Hum Antibodies 16 99 105 18334745 1:CAS:528: DC%2BD1cXislWntbk%3D
75. L Vitale D Blanset I Lowy T O'Neill J Goldstein SF Little GP Andrews G Dorough RK Taylor T Keler 2006 Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity Infect Immun 74 5840 5847 16988263 10.1128/IAI.00712-06 1:CAS:528:DC%2BD28XhtVGlsr%2FP
76. F Wang P Ruther I Jiang R Sawada-Hirai SM Sun R Nedellec PR Morrow AS Kang 2004 Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assembly Hum Antibodies 13 105 110 15671576 1:CAS:528:DC%2BD2MXmtlKlug%3D%3D
77. P Zhao X Liang J Kalbfleisch HM Koo B Cao 2003 Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model Hum Antibodies 12 129 135 15156101 1:CAS:528:DC%2BD2cXjsV2mt7w%3D
78. NK Lim JH Kim MS Oh S Lee SY Kim KS Kim HJ Kang HJ Hong KS Inn 2005 An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin Infect Immun 73 6547 6551 16177329 10.1128/IAI.73.10.6547-6551.2005 1:CAS:528:DC%2BD2MXhtVyhurjE
79. DG Bouzianas 2010 Current and future medical approaches to combat the anthrax threat J Med Chem 53 4305 4331 20102155 10.1021/jm901024b 1:CAS:528:DC%2BC3cXhtVGgsro%3D
80. K Sherer Y Li X Cui PQ Eichacker 2007 Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy Am J Respir Crit Care Med 175 211 221 17095744 10.1164/rccm.200608-1239CP 1:CAS:528:DC%2BD2sXivF2ktbc%3D
81. Medical Letter consultants (1998) Anthrax vaccine. Med Lett Drugs Ther 40:52-53
82. L Baillie T Townend N Walker U Eriksson D Williamson 2004 Characterization of the human immune response to the UK anthrax vaccine FEMS Immunol Med Microbiol 42 267 270 15364114 10.1016/j.femsim.2004.05.011 1:CAS:528:DC%2BD2cXnsFSku7c%3D
83. NJ Vietri BK Purcell JV Lawler EK Leffel P Rico CS Gamble NA Twenhafel BE Ivins HS Heine R Sheeler ME Wright AM Friedlander 2006 Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax Proc Natl Acad Sci U S A 103 7813 7816 16672361 10.1073/pnas.0602748103 1:CAS:528:DC%2BD28XlsVGksL4%3D
84. Centers for Disease Control and Prevention (CDC) 2002 Use of anthrax vaccine in response to terrorism: supplemental recommendations of the advisory committee on immunization practices MMWR Morb Mortal Wkly Rep 51 1024 1026
85. Centers for Disease Control and Prevention (CDC) (2008) Summary report of the meeting of the advisory committee on immunization practices (ACIP). Atlanta, 22-23 October 2008. Available via www.cdc.gov/vaccines/recs/acip/ downloads/min-archive/min-oct08.pdf. Accessed 27 Jan 2012
86. K Sherer Y Li X Cui X Li M Subramanian MW Laird M Moayeri SH Leppla Y Fitz J Su PQ Eichacker 2007 Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model Crit Care Med 35 1560 1567 17452924 10.1097/01.CCM.0000266535.95770.A2
87. Y Li X Cui J Su M Haley H Macarthur K Sherer M Moayeri SH Leppla Y Fitz PQ Eichacker 2009 Norepinephrine increases blood pressure but not survival with anthrax lethal toxin in rats Crit Care Med 37 1348 1354 19242337 10.1097/CCM.0b013e31819cee38 1:CAS:528:DC%2BD1MXjsFelu7c%3D
88. AV Barochia X Cui J Sun Y Li SB Solomon TS Migone GM Subramanian SD Bolmer PQ Eichacker 2012 Protective antigen antibody augments hemodynamic support in anthrax lethal toxin shock in canines J Infect Dis 205 818 829 22223857 10.1093/infdis/jir834 1:CAS:528:DC%2BC38XisVGktrw%3D
89. JA Jernigan DS Stephens DA Ashford C Omenaca MS Topiel M Galbraith M Tapper TL Fisk S Zaki T Popovic RF Meyer CP Quinn SA Harper SK Fridkin JJ Sejvar CW Shepard M McConnell J Guarner WJ Shieh JM Malecki JL Gerberding JM Hughes BA Perkins ABI Team 2001 Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States Emerging Infect Dis 7 933 944 11747719 10.3201/eid0706.010604 1:STN:280:DC%2BD3MnpvFWhtQ%3D%3D
90. JJ Walsh N Pesik CP Quinn V Urdaneta CA Dykewicz AE Boyer J Guarner P Wilkins KJ Norville JR Barr SR Zaki JB Patel SP Reagan JL Pirkle TA Treadwell NR Messonnier LD Rotz RF Meyer DS Stephens 2007 A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor Clin Infect Dis 44 968 971 17342650 10.1086/512372
91. JJ Sejvar FC Tenover DS Stephens 2005 Management of anthrax meningitis Lancet Infect Dis 5 287 295 15854884 10.1016/S1473-3099(05)70113-4
92. JY Doust A Sarkarzadeh K Kavoossi 1968 Corticosteroid in treatment of malignant edema of chest wall and neck (anthrax) Dis Chest 53 773 774 5653754 10.1378/chest.53.6.773 1:STN:280:DyaF1c3nsF2jsw%3D%3D
93. DJ Lanska 2002 Anthrax meningoencephalitis Neurology 59 327 334 12177364 10.1212/WNL.59.3.327
94. JI Webster LH Tonelli M Moayeri SS Simons Jr SH Leppla EM Sternberg 2003 Anthrax lethal factor represses glucocorticoid and progesterone receptor activity Proc Natl Acad Sci U S A 100 5706 5711 12724519 10.1073/pnas.1036973100 1:CAS:528:DC%2BD3sXjvFOlsrs%3D
95. JC Pile JD Malone EM Eitzen AM Friedlander 1998 Anthrax as a potential biological warfare agent Arch Intern Med 158 429 434 9508220 10.1001/archinte.158.5.429 1:STN:280:DyaK1c7mslKntw%3D%3D
96. Heymann DL, Association American Public Health (2008) Control of communicable diseases manual, 19th edn. American Public Health Association, Washington
97. Mandell GL, Douglas RG, Bennett JE et al (2005) Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 6th edn. Elsevier Churchill Livingstone, Philadelphia